A perfect site for biotech and pharma companies!
Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...More details
Infrastructure and R&D solutions for biotech and pharmaceutical industries
The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...More details
Biotech and pharma at PARK INNOVAARE
PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...More details
Corporate Innovation Makeover: Excubation rules for the core business
This blog post is dedicated to the final three Excubation rules, and thus concludes our Corporate Innovation Makeover series. These three rules focus on...More details
Corporate Innovation Makeover: Excubation rules 3 and 4
Building on the excubation conversation we started in this blog series, and having introduced first two rules of the approach, we dive here into the next...More details
Unprecedented speed and success rate with delivering ligand-bound GPCR structures
Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...More details
How can KPI steer your innovation process?
PARK INNOVAARE works at the interface of technology-driven companies and public research, such as at the nearby Paul Scherrer Institute (PSI). In one of...More details
Methodically secret: what should you consider with respect to your know-how and trade secrets?
It falls short of a full appreciation of innovation to consider only patentable inventions. Process innovation, for instance, is usually not patentable....More details
Radio-diagnosis paves the way for better therapy
In March 2017, the Strategy Committee at the Paul Scherrer Institute (PSI) gave its green light for a joint initiative with PARK INNOVAARE to join in realizing...More details
Crystallization at its best
The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...More details
Electron diffraction opens new possibilities for structure-based drug discovery
Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. The reason why the atomic structure...More details